Author: Gabriel Omarsson

The Evolution From Single to Triple Receptor Targeting The development of GLP-1 receptor agonists represents one of the most significant advances in metabolic research over the past decade. What began with single-receptor compounds like semaglutide has rapidly evolved into dual and triple agonists that target multiple metabolic pathways simultaneously — each generation producing larger effect…

A concise comparison of Semax and Selank — two Russian-developed neuropeptides with distinct mechanisms, cognitive effects, and research applications.

A concise comparison of Sermorelin and CJC-1295 — two GHRH-based peptides with different half-lives, mechanisms, and research applications.

A concise comparison of BPC-157 and TB-500 — their distinct mechanisms, research applications, and why they are often studied together.

What Does the Research Say About Peptides and Aging? Aging research has undergone a fundamental shift over the past two decades. Once considered an inevitable, untreatable process, biological aging is now understood as a collection of measurable, interconnected mechanisms — telomere shortening, mitochondrial dysfunction, cellular senescence, NAD+ decline, and gene expression changes. Each of these…